Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion
(Reuters) -Eli Lilly will acquire Morphic Holding for $3.2 billion, the companies said on Monday,...
(Reuters) -Eli Lilly will acquire Morphic Holding for $3.2 billion, the companies said on Monday,...
SAN FRANCISCO (Reuters) – A surge in the U.S. labor force in recent years may...
By Seher Dareen (Reuters) – Devon Energy said on Monday it had entered into a...
(Reuters) – Tropical Storm Beryl lashed Texas with strong winds and torrential rain on Monday...
By Jennifer Rigby LONDON (Reuters) – The bird flu strain found in cows in the...
By Ernest Scheyder (Reuters) – Mining trade groups plan to push Washington to revive and...
By Jonathan Stempel NEW YORK (Reuters) – Elon Musk wants to dismiss a lawsuit by...
(Reuters) -“Fortnite” maker Epic Games said on Friday Apple was impeding its attempts to set...
(Reuters) – A government report showing the U.S. labor market continues to cool could give...
LONDON (Reuters) – The amount of cryptocurrency stolen in hacks globally more than doubled in...